Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 28


Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation.

Skeppholm M, Al-Aieshy F, Berndtsson M, Al-Khalili F, Rönquist-Nii Y, Söderblom L, Östlund AY, Pohanka A, Antovic J, Malmström RE.

Thromb Res. 2015 Jul;136(1):148-53. doi: 10.1016/j.thromres.2015.04.030. Epub 2015 Apr 30.


Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.

Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M.

Circulation. 2015 Jun 23;131(25):2176-84. doi: 10.1161/CIRCULATIONAHA.114.014343. Epub 2015 Apr 24.


Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman-Kull V, Levin LÅ.

Europace. 2015 Jul;17(7):1023-9. doi: 10.1093/europace/euv083. Epub 2015 Apr 12.


Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.


[Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation].

Al-Khalili F, Lindström C.

Lakartidningen. 2014 Oct 1-7;111(40):1720-2. Swedish. No abstract available.


Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.


Darapladib for preventing ischemic events in stable coronary heart disease.

STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L.

N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.


Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.


Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.


Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.


Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.

Lip GY, Rasmussen LH, Olsson SB, Zetterstrand S, Stahre C, Bylock A, Aunes-Jansson M, Eriksson U, Wåhlander K; Steering Committee.

Thromb Res. 2011 Feb;127(2):91-9. doi: 10.1016/j.thromres.2010.11.012. Epub 2010 Dec 18.


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].


Renal dysfunction as a predictor of long-term mortality in middle-aged women following an acute coronary syndrome.

Holzmann MJ, Janszky I, Al-Khalili F, Schenck-Gustafsson K.

J Womens Health (Larchmt). 2010 Aug;19(8):1487-91. doi: 10.1089/jwh.2009.1841.


The effects of exercise capacity and sedentary lifestyle on haemostasis among middle-aged women with coronary heart disease.

Nagy E, Janszky I, Eriksson-Berg M, Al-Khalili F, Schenck-Gustafsson K.

Thromb Haemost. 2008 Nov;100(5):899-904.


Physical activity and exercise performance predict long-term prognosis in middle-aged women surviving acute coronary syndrome.

Al-Khalili F, Janszky I, Andersson A, Svane B, Schenck-Gustafsson K.

J Intern Med. 2007 Feb;261(2):178-87.


Heart rate variability in long-term risk assessment in middle-aged women with coronary heart disease: The Stockholm Female Coronary Risk Study.

Janszky I, Ericson M, Mittleman MA, Wamala S, Al-Khalili F, Schenck-Gustafsson K, Orth-Gomer K.

J Intern Med. 2004 Jan;255(1):13-21.


Significant predictors of poor prognosis in women aged </=65 years hospitalized for an acute coronary event.

Al-Khalili F, Svane B, Janszky I, Rydén L, Orth-Gomér K, Schenck-Gustafsson K.

J Intern Med. 2002 Dec;252(6):561-9.


Cortisol and vital exhaustion in relation to significant coronary artery stenosis in middle-aged women with acute coronary syndrome.

Koertge J, Al-Khalili F, Ahnve S, Janszky I, Svane B, Schenck-Gustafsson K.

Psychoneuroendocrinology. 2002 Nov;27(8):893-906.


Changes in Systolic and Diastolic Function Indexes Throughout Dobutamine Stress Echocardiography in Healthy Volunteers and Patients with Ischemic Heart Disease.

Edner M, Brodin Lk LÅ, Al-Khalili F, Svane B, Moor E, StÅhle A, Nordlander R.

Echocardiography. 1998 Oct;15(7):625-634.


Intracoronary ultrasound measurements in women with myocardial infarction without significant coronary lesions.

al-Khalili F, Svane B, Di Mario C, Prati F, Mallus MT, Rydén L, Schenck-Gustafsson K.

Coron Artery Dis. 2000 Dec;11(8):579-84.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk